FOXP3 and colorectal carcinoma: Lin et al. identified two subsets of Tregs based on Foxp3 and CD45RA expression which were increased in CRC patients: strongly suppressive activated Tregs (Foxp3highCD45RA–) and non-suppressive Tregs (Foxp3low CD45RA–).